Rural v. Urban Aspects of Cancer: First-Year Data from the Mississippi Central Cancer Registry von Higginbotham, John C., Moulder, Judy, Currier, Mary

Volltext

Tornado-Related Fatalities — Five States, Southeastern United States, April 25–28, 2011 von Casey-Lockyer, Mary, Donald, Catherine Molchan, Moulder, Judy, Aderhold, Deborah, Harris, Doreen, Woodall, Gary, Young, Douglas, MacAloney, Brenton, Carbin, Gregory, Morrison, Melissa, Chester, Thomas, Roth, Jay, Noe, Rebecca S, Schnall, Amy, Wolkin, Amy, Vagi, Sara, Mertzlufft, Caitlin E, Sugerman, David, Chiu, Cindy

Volltext

Gastric carcinoma among younger individuals in Mississippi von Hall, T J, Moulder, J, Hsu, H S, Achord, J, Scott-Conner, C E

Volltext

EARLY PRESENTATION OF GASTRIC CARCINOMA IN MISSISSIPPI von Hall, Terrence J., Moulder, Judy, Hsu, Henry S., Achord, James, Scott-Conner, Carol

Volltext

Tornado-Related Fatalities - Five States, Southeastern United States, April 25-28, 2011 von Casey-Lockyer, Mary, Donald, Catherine Molchan, Moulder, Judy, Aderhold, Deborah, Harris, Doreen, Woodall, Gary, Young, Douglas, MacAloney, Brenton, Carbin, Gregory, Morrison, Melissa, Chester, Thomas, Roth, Jay, Noe, Rebecca S, Schnall, Amy, Wolkin, Amy, Vagi, Sara, Mertzlufft, Caitlin E, Sugerman, David, Chiu, Cindy

Volltext

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer von Rugo, Hope S, Olopade, Olufunmilayo I, DeMichele, Angela, Yau, Christina, van ’t Veer, Laura J, Buxton, Meredith B, Hogarth, Michael, Hylton, Nola M, Paoloni, Melissa, Perlmutter, Jane, Symmans, W. Fraser, Yee, Douglas, Chien, A. Jo, Wallace, Anne M, Kaplan, Henry G, Boughey, Judy C, Haddad, Tufia C, Albain, Kathy S, Liu, Minetta C, Isaacs, Claudine, Khan, Qamar J, Lang, Julie E, Viscusi, Rebecca K, Pusztai, Lajos, Moulder, Stacy L, Chui, Stephen Y, Kemmer, Kathleen A, Elias, Anthony D, Edmiston, Kirsten K, Euhus, David M, Haley, Barbara B, Nanda, Rita, Northfelt, Donald W, Tripathy, Debasish, Wood, William C, Ewing, Cheryl, Schwab, Richard, Lyandres, Julia, Davis, Sarah E, Hirst, Gillian L, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Adaptive Randomization of Neratinib in Early Breast Cancer von Park, John W, Liu, Minetta C, Yee, Douglas, Yau, Christina, van ’t Veer, Laura J, Symmans, W. Fraser, Paoloni, Melissa, Perlmutter, Jane, Hylton, Nola M, Hogarth, Michael, DeMichele, Angela, Buxton, Meredith B, Chien, A. Jo, Wallace, Anne M, Boughey, Judy C, Haddad, Tufia C, Chui, Stephen Y, Kemmer, Kathleen A, Kaplan, Henry G, Isaacs, Claudine, Nanda, Rita, Tripathy, Debasish, Albain, Kathy S, Edmiston, Kirsten K, Elias, Anthony D, Northfelt, Donald W, Pusztai, Lajos, Moulder, Stacy L, Lang, Julie E, Viscusi, Rebecca K, Euhus, David M, Haley, Barbara B, Khan, Qamar J, Wood, William C, Melisko, Michelle, Schwab, Richard, Helsten, Teresa, Lyandres, Julia, Davis, Sarah E, Hirst, Gillian L, Sanil, Ashish, Esserman, Laura J, Berry, Donald A

Volltext

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer von DeMichele, Angela, Yee, Douglas, Berry, Donald A, Albain, Kathy S, Benz, Christopher C, Boughey, Judy, Buxton, Meredith, Chia, Stephen K, Chien, Amy J, Chui, Stephen Y, Clark, Amy, Edmiston, Kirsten, Elias, Anthony D, Forero-Torres, Andres, Haddad, Tufia C, Haley, Barbara, Haluska, Paul, Hylton, Nola M, Isaacs, Claudine, Kaplan, Henry, Korde, Larissa, Leyland-Jones, Brian, Liu, Minetta C, Melisko, Michelle, Minton, Susan E, Moulder, Stacy L, Nanda, Rita, Olopade, Olufunmilayo I, Paoloni, Melissa, Park, John W, Parker, Barbara A, Perlmutter, Jane, Petricoin, Emanuel F, Rugo, Hope, Symmans, Fraser, Tripathy, Debasish, van't Veer, Laura J, Viscusi, Rebecca K, Wallace, Anne, Wolf, Denise, Yau, Christina, Esserman, Laura J

Volltext

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial von Clark, Amy S., Yau, Christina, Wolf, Denise M., Petricoin, Emanuel F., van ‘t Veer, Laura J., Yee, Douglas, Moulder, Stacy L., Wallace, Anne M., Chien, A. Jo, Isaacs, Claudine, Boughey, Judy C., Albain, Kathy S., Kemmer, Kathleen, Haley, Barbara B., Han, Hyo S., Forero-Torres, Andres, Elias, Anthony, Lang, Julie E., Ellis, Erin D., Yung, Rachel, Tripathy, Debu, Nanda, Rita, Wulfkuhle, Julia D., Brown-Swigart, Lamorna, Gallagher, Rosa I., Helsten, Teresa, Roesch, Erin, Ewing, Cheryl A., Alvarado, Michael, Crane, Erin P., Buxton, Meredith, Clennell, Julia L., Paoloni, Melissa, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Steeg, Katherine, Asare, Adam, Matthews, Jeffrey B., Berry, Scott, Sanil, Ashish, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Hylton, Nola M., Berry, Donald A., Esserman, Laura J., DeMichele, Angela M.

Volltext

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer von Yee, Douglas, Isaacs, Claudine, Wolf, Denise M., Yau, Christina, Haluska, Paul, Giridhar, Karthik V., Forero-Torres, Andres, Jo Chien, A., Wallace, Anne M., Pusztai, Lajos, Albain, Kathy S., Ellis, Erin D., Beckwith, Heather, Haley, Barbara B., Elias, Anthony D., Boughey, Judy C., Kemmer, Kathleen, Yung, Rachel L., Pohlmann, Paula R., Tripathy, Debu, Clark, Amy S., Han, Hyo S., Nanda, Rita, Khan, Qamar J., Edmiston, Kristen K., Petricoin, Emanuel F., Stringer-Reasor, Erica, Falkson, Carla I., Majure, Melanie, Mukhtar, Rita A., Helsten, Teresa L., Moulder, Stacy L., Robinson, Patricia A., Wulfkuhle, Julia D., Brown-Swigart, Lamorna, Buxton, Meredith, Clennell, Julia L., Paoloni, Melissa, Sanil, Ashish, Berry, Scott, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Asare, Adam L., Matthews, Jeffrey B., Hylton, Nola M., DeMichele, Angela, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Fraser Symmans, W., van‘t Veer, Laura J., Berry, Donald A., Esserman, Laura J.

Volltext

Abstract CT042: Efficacy of T-DM1+pertuzumab over standard therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL von DeMichele, Angela M., Moulder, Stacy, Buxton, Meredith, Yee, Douglas, Wallace, Anne, Chien, Jo, Isaacs, Claudine, Albain, Kathy, Boughey, Judy, Kemmer, Kathleen, Haley, Barbara, Lang, Julie, Kaplan, Henry, Minton, Susan, Forero, Andres, Elias, Anthony, Nanda, Rita, Korde, Larissa, Schwab, Richard, Melisko, Michelle, Sanil, Ashish, Hogarth, Michael, Hylton, Nola, Paoloni, Melissa, Symmans, Fraser, Perlmutter, Jane, Lyandres, Julia, Yau, Christina, Berry, Don, Esserman, Laura

Volltext

Abstract CT106: Efficacy of pertuzumab/trastuzumab/paclitaxel over standard trastuzumab/paclitaxel therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL von Buxton, Meredith, DeMichele, Angela M., Chia, Stephen, van't Veer, Laura, Chien, Jo, Wallace, Anne, Kaplan, Henry, Lang, Julie, Yee, Douglas, Isaacs, Claudine, Moulder, Stacy, Albain, Kathy, Boughey, Judy, Kemmer, Kathleen, Haley, Barbara, Minton, Susan, Forero, Andres, Nanda, Rita, Elias, Anthony, Korde, Larissa, Viscuzi, Rebecca, Rugo, Hope, Schwab, Richard, Symmans, Fraser, Paoloni, Melissa, Hylton, Nola, Hogarth, Michael, Lyandres, Julia, Perlmutter, Jane, Sanil, Ashish, Yau, Christina, Esserman, Laura, Berry, Don

Volltext

Abstract P3-06-29: MammaPrint High1/High2 risk class as a biomarker of response to neratinib plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL von Yau, Christina, Wolf, Denise M, Sanil, Ashish, Chien, Jo, Wallace, Anne, Boughey, Judy, Yee, Doug, Tripathy, Debu, DeMichele, Angela, Nanda, Rita, Chiu, Steven, Isaacs, Claudine, Albain, Kathy, Kaplan, Hank, Moulder, Stacey, Viscusi, Rebecca, Northfelt, Donald, Edmiston, Kirsten, Elias, Anthony, Styblo, Toncred, Haley, Barbara, Brown-Swigart, Lamorna, Flynn, Susan, Hirst, Gillian L, Buxton, Meredith, Hylton, Nola, Paoloni, Melissa, Symmans, W Fraser, Esserman, Laura, Berry, Don, Liu, Minetta C, Park, John W, van 't Veer, Laura

Volltext

Abstract P3-06-25: MammaPrint High1/High2 risk class as a biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy for breast cancer in the I-SPY 2 TRIAL von Wolf, Denise M, Yau, Christina, Sanil, Ashish, Chien, Jo, Wallace, Anne, DeMichele, Angela, Kaplan, Hank, Yee, Doug, Isaacs, Claudine, Albain, Kathy, Viscuzi, Rebecca, Boughey, Judy, Moulder, Stacey, Chui, Steven, Khan, Qamar, Styblo, Toncred, Edmiston, Kirsten, Northfelt, Donald, Elias, Anthony, Haley, Barbara, Tripathy, Debu, Brown-Swigart, Lamorna, Flynn, Susan, Hirst, Gillian, Buxton, Meredith, Hylton, Nola, Paoloni, Melissa, Symmans, Fraser, Esserman, Laura, Berry, Don, Rugo, Hope, Olopade, Olufunmilayo I., van 't Veer, Laura

Volltext

Abstract CT227: Neratinib plus standard neoadjuvant therapy for high-risk breast cancer: Efficacy results from the I-SPY 2 TRIAL von Park, John W., Liu, Minetta C., Yee, Douglas, DeMichele, Angela, Veer, Laura van 't, Hylton, Nola, Symmans, Fraser, Buxton, Meredith B., Chien, A. Jo, Wallace, Amy, Melisko, Michelle, Schwab, Richard, Boughey, Judy, Tripathy, Debashish, Kaplan, Hank, Nanda, Rita, Chui, Stephen, Albain, Kathy S., Moulder, Stacy, Elias, Anthony, Lang, Julie E., Edminston, Kirsten, Northfelt, Donald, Euhus, David, Khan, Qamar, Lyandres, Julia, Davis, Sarah E., Yau, Christina, Sanil, Ashish, Esserman, Laura J., Berry, Donald A.

Volltext